none610siBackground The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable comparisons of health loss over time and across causes, age-sex groups, and countries. The GBD can be used to generate summary measures such as disability-adjusted life-years (DALYs) and healthy life expectancy (HALE) that make possible comparative assessments of broad epidemiological patterns across countries and time. These summary measures can also be used to quantify the component of variation in epidemiology that is related to sociodemographic development. Methods We used the published GBD 2013 data...
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled syst...
open769siBackground Improving survival and extending the longevity of life for all populations requi...
open630siThis article has been corrected. See Lancet. 2017 January 07; 389(10064): e1. See "GBD 201...
none722siBackground: The Global Burden of Disease, Injuries, and Risk Factor study 2013 (GBD 2013) i...
open720siBackground Up-to-date evidence on levels and trends for age-sex-specifi c all-cause and cau...
none727siBackground As mortality rates decline, life expectancy increases, and populations age, non-...
none642siBackground: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016)...
open870siFunders: Bill AMP; Melinda Gates Foundation Cancer Foundation Finland sr 180129 160100 ...
none782siBackground: Detailed assessments of mortality patterns, particularly age-specific mortality...
444siHumans vary substantially in their willingness to take risks. In a combined sample of over 1 mi...
none3597The genetic make-up of an individual contributes to the susceptibility and response to viral...
open679siBackground Up-to-date evidence about levels and trends in disease and injury incidence, pre...
377siBackground: Patient factors associated with urinary tract cancer can be used to risk stratify p...
279siBody-fat distribution is a risk factor for adverse cardiovascular health consequences. We analy...
Full list of authors: EHT MWL Science Working Group; Algaba, J. C.; Anczarski, J.; Asada, K.; Baloko...
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled syst...
open769siBackground Improving survival and extending the longevity of life for all populations requi...
open630siThis article has been corrected. See Lancet. 2017 January 07; 389(10064): e1. See "GBD 201...
none722siBackground: The Global Burden of Disease, Injuries, and Risk Factor study 2013 (GBD 2013) i...
open720siBackground Up-to-date evidence on levels and trends for age-sex-specifi c all-cause and cau...
none727siBackground As mortality rates decline, life expectancy increases, and populations age, non-...
none642siBackground: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016)...
open870siFunders: Bill AMP; Melinda Gates Foundation Cancer Foundation Finland sr 180129 160100 ...
none782siBackground: Detailed assessments of mortality patterns, particularly age-specific mortality...
444siHumans vary substantially in their willingness to take risks. In a combined sample of over 1 mi...
none3597The genetic make-up of an individual contributes to the susceptibility and response to viral...
open679siBackground Up-to-date evidence about levels and trends in disease and injury incidence, pre...
377siBackground: Patient factors associated with urinary tract cancer can be used to risk stratify p...
279siBody-fat distribution is a risk factor for adverse cardiovascular health consequences. We analy...
Full list of authors: EHT MWL Science Working Group; Algaba, J. C.; Anczarski, J.; Asada, K.; Baloko...
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled syst...
open769siBackground Improving survival and extending the longevity of life for all populations requi...
open630siThis article has been corrected. See Lancet. 2017 January 07; 389(10064): e1. See "GBD 201...